Exchange: NASDAQ·Updated 07:30 PM EST
BWAY logo

BWAY Brainsway Ltd.

$8.40
$0.25
(2.86%)
Today
Closed $8.48
$0.08
(0.94%)
After Hours
Reported EarningsNov 10
Mkt Cap$341.37M
Vol109,521.00

About BWAY

Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut in 2003 and is headquartered in Jerusalem, Israel.
41

Bearish Sentiment

How do you feel about BWAY?

Sebastian71
$BWAY why has this stock lost so much value over the past month ?$BWAY it seems to have such a niche in the field of treating mental health.
StocktwitsEarnings
$BWAY Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.05 up 25.00% YoY • Reported revenue of $18.15M up 34.34% YoY • BrainsWay expects full-year 2026 revenue, operating income margin and Adjusted EBITDA at the upper end of previously issued guidance, with potential to modestly exceed guidance.
shoc24
$BWAY reports earnings tomorrow before the open. I'm bullish heading into the report: BWAY has beaten EPS estimates in 7 of its last 8 reports, according to Stock Meadow.

Advertisement|Remove ads.